These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 761001)

  • 1. Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.
    Day JL; Simpson N; Metcalfe J; Page RL
    Br Med J; 1979 Jan; 1(6156):77-80. PubMed ID: 761001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of atenolol and propranolol upon lipolysis.
    Deacon SP
    Br J Clin Pharmacol; 1978 Feb; 5(2):123-5. PubMed ID: 339933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of beta-blocking drugs on glucose metabolism in hypertensive, non-diabetic patients.
    Groop L; Tötterman KJ; Harno K; Gordin A
    Acta Med Scand; 1983; 213(1):9-14. PubMed ID: 6338683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nonselective and beta-1-selective blockade on glucose metabolism and hormone responses during insulin-induced hypoglycemia in normal man.
    Lauridsen UB; Christensen NJ; Lyngsøe J
    J Clin Endocrinol Metab; 1983 May; 56(5):876-82. PubMed ID: 6339540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of pretreatment with atenolol and propranolol on sympatho-adrenal and cardiovascular responses to acute insulin-induced hypoglycaemia in the hypertensive patient].
    Cannella G; Picotti GB; Giambelli A; Scolari F; Cesura AM; Tosoni S; Maiorca R
    G Ital Cardiol; 1982; 12(12):884-8. PubMed ID: 6763907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic mechanisms in control of plasma lipid concentrations.
    Day JL; Metcalfe J; Simpson CN
    Br Med J (Clin Res Ed); 1982 Apr; 284(6323):1145-8. PubMed ID: 6122483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension.
    Epstein SE; LUbbe WF
    S Afr Med J; 1977 Nov; 52(22):875-9. PubMed ID: 343273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol.
    Hansson L; Westerlund A; Aberg H; Karlberg BE
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):361-5. PubMed ID: 786662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients.
    Lehtonen A
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):549-51. PubMed ID: 3154682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of metabolic and hormonal responses to somatostatin and propranolol in man.
    Giugliano D; Torella R; Sgambato S
    Acta Diabetol Lat; 1979; 16(1):77-81. PubMed ID: 452822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension.
    Sheu WH; Swislocki AL; Hoffman B; Chen YD; Reaven GM
    Am J Hypertens; 1991 Mar; 4(3 Pt 1):199-205. PubMed ID: 2043298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of a change in antihypertensive treatment.
    Lithell H; Aberg H; Selinus I
    Am J Med; 1986 Feb; 80(2A):114-9. PubMed ID: 3511690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent effects of atenolol, practolol and propranolol on the peripheral metabolic changes induced by dynamic exercise in healthy men.
    Laustiola K; Uusitalo A; Koivula T; Sovijärvi A; Seppälä E; Nikkari T; Vapaatalo H
    Eur J Clin Pharmacol; 1983; 25(3):293-7. PubMed ID: 6628516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
    Bowden CR; Marchione CS
    J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.
    Pollare T; Lithell H; Selinus I; Berne C
    BMJ; 1989 Apr; 298(6681):1152-7. PubMed ID: 2500169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations.
    Golay A; Swislocki AL; Chen YD; Jaspan JB; Reaven GM
    J Clin Endocrinol Metab; 1986 Aug; 63(2):481-4. PubMed ID: 3522620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of atenolol and propranolol during insulin-induced hypoglycaemia.
    Deacon SP; Barnett D
    Br Med J; 1976 Jul; 2(6030):272-3. PubMed ID: 8184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol effect on plasma glucose, free fatty acid, insulin, and growth hormone in Graves' disease.
    Ortigosa JL; Mendoza F; Argote RM; Garcia G; Cervantes C; Parra A
    Metabolism; 1976 Nov; 25(11):1201-7. PubMed ID: 989880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial.
    Punda A; Polić S; Rumboldt Z; Bagatin J; Marković V; Lukin A
    Croat Med J; 2005 Apr; 46(2):219-24. PubMed ID: 15849842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.